Pazopanib Maintenance Phase II

NCT02207309 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped poor recruitment

Conditions

Sarcoma

Interventions

DRUG: Pazopanib
DRUG: Placebo (for Pazopanib)

Sponsor

Ludwig-Maximilians - University of Munich